COLON ERDERLY LOW DOSE

Evaluation of Bevacizumab in Combination With First-Line Chemotherapy in Patients Aged 75 Years of Older With Metastatic Colorectal Adenocarcinoma (Prodige20)

NCT01900717 ·Status: COMPLETED ·Phase: PHASE2

A Study of Second- and Later-line Palliative Chemotherapy in Patients With Metastatic Colorectal Cancer.

NCT07263178 ·Status: RECRUITING

Study of Target-Guided Chemotherapy in Metastatic Colorectal Patients

NCT01453257 ·Status: COMPLETED ·Phase: PHASE2

An Observational Study of Bevacizumab in Combination With 5-FU-Based Chemotherapy in Chinese Participants With Metastatic Colorectal Cancer

NCT01319877 ·Status: COMPLETED

Irinotecan With or Without Capecitabine as Second-Line Therapy in Treating Older Patients With Progressive, Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

NCT00303745 ·Status: UNKNOWN ·Phase: PHASE2

Regorafenib in Combination With Multimodal Metronomic Chemotherapy for Chemo-resistant Metastatic Colorectal Cancers

NCT06425133 ·Status: RECRUITING ·Phase: PHASE2

QoL in mCRC Elderly Patients Receiving First-line Therapy Based on Simplified Geriatric Parameters.

NCT03828227 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Capecitabine and Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer

NCT00104689 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Regorafenib Maintenance Therapy in Patients With Metastatic Colorectal Cancer (mCRC)

NCT05818267 ·Status: RECRUITING ·Phase: NA

Retrospective Study on the Use of Immunotherapy in Patients With MSI-H Metastatic Colorectal Cancer

NCT04612309 ·Status: ACTIVE_NOT_RECRUITING

Adjuvant Chemotherapy In Elderly With Colon Cancer Stage III

NCT02978612 ·Status: COMPLETED ·Phase: PHASE2

Chemotherapy and/or Metastasectomy in Treating Patients With Metastatic Colorectal Adenocarcinoma With Lung Metastases

NCT03599752 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Phase II Study of CP-4055 as Second Line Therapy in Patients With Advanced Colorectal Cancer

NCT00498407 ·Status: COMPLETED ·Phase: PHASE2

A Study of Pyrotinib Combined With Capecitabine for Metastatic HER-2 Positive Colorectal Cancer

NCT04227041 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Sequential Versus Combination Chemotherapy in Advanced Colorectal Carcinoma

NCT00312000 ·Status: COMPLETED ·Phase: PHASE3

PET/CT Scan as a Tool to Rationalize the Treatment of Patients With Advanced ColoRectal Cancer Undergoing First-line Medical Treatment

NCT02618850 ·Status: UNKNOWN ·Phase: NA

Sym004 vs Standard of Care in Subjects With Metastatic Colorectal Cancer

NCT02083653 ·Status: COMPLETED ·Phase: PHASE2

Phase II Trial of Abraxane and Capecitabine in Metastatic Colon Cancer (COL 01)

NCT00625573 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and the Safety of Regorafenib in Patients Aged More Than 70 Years With a Metastatic Colorectal Adenocarcinoma .

NCT02788006 ·Status: COMPLETED ·Phase: PHASE2

Efficacy/Safety Study of Bevacizumab,Capecitabine,Oxaliplatin to Metastatic Colorectal Adenocarcinoma Elderly Patients.

NCT01067053 ·Status: UNKNOWN ·Phase: PHASE2

The Study of JMT101 Combined With Irinotecan as a ≥3rd-Line Treatment in Metastatic Colorectal Cancer

NCT07134205 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Study of Biomarkers in Patients Undergoing Chemotherapy for Metastatic Colorectal Cancer

NCT00559676 ·Status: COMPLETED ·Phase: PHASE4

A Real-World Study to Learn More About the Order of Different Treatments and Their Effects in People With Metastatic Colorectal Cancer Receiving Their Third and Fourth Line of Treatment

NCT06137170 ·Status: COMPLETED

Regorafenib Combined With TAS-102 Versus Regorafenib Monotherapy in Third or Later Line Therapy of mCRC

NCT05970705 ·Status: RECRUITING ·Phase: PHASE2

Galunisertib Combined With Capecitabine in Advanced CRC With PM

NCT05700656 ·Status: RECRUITING ·Phase: PHASE1/PHASE2